VZV: Molecular basis of persistence (latency and reactivation)

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 689-699

  Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929288239     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.039     Document Type: Chapter

References (77)

1. Annunziato, P., LaRussa, P., Lee, P. et al. (1998). Evidence of latent varicella-zoster virus in rat dorsal root ganglia J. Infect. Dis., 178 (Suppl 1), S48-S51.
2. Arvin, A. M., Sharp, M., Moir, M. et al. (2002). Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicellazoster virus. Viral Immunol., 15, 507-516.
3. Assouline J. G., Levin, M. J., Major, E. O., Forghani, B., Straus, S. E., and Ostrove, J. M. (1990). Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons. Virology, 179, 834-844.
4. Baiker, A., Fabel, K., Cozzio, A. et al. (2004). Varicella-zoster virus infection of human neural cells in vivo. Proc. Natl Acad. Sci. USA, 101, 10792-10797
5. Bontems, S., Di Valentin, E., Baudoux, L., Rentier, B., Sadzot-Delvaux, C., and Piette, J. (2002). Phosphorylation of varicella-zoster virus IE63 protein by casein kinases inuences its cel-lular localization and gene regulation activity. J. Biol. Chem., 277, 21050-21060.
6. Boucaud, D., Yoshitake, H., Hay, J., and Ruyechan, W. (1998). The varicella-zoster virus (VZV) open-reading frame 29 protein acts as a modulator of a late VZV gene promoter. J. Infect. Dis., 178 (Suppl. 1), S34-S38.
7. Brunell, P. A., Ren, L. C., Cohen, J. I., and Straus, S. E. (1999). Viral gene expression in rat trigeminal ganglia following neona-tal infection with varicella-zoster virus. J. Med. Virol., 58, 286-290.
8. Chen J. J., Gershon, A. A., Li, Z. S., Lungu, O., and Gershon, M. D. (2003). Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J. Med. Virol., 70 (Suppl. 1), S71-S78
9. Clarke, P., Beer, T., Cohrs, R., and Gilden, D. H. (1995). Conguration of latent varicella-zoster virus DNA. J. Virol., 69, 8151-8154.
10. Clarke, P., Matlock, W. L., Beer, T. and Gilden, D. H. (1996). A simian varicella virus (SVV) homolog to varicella-zoster virus gene 21 is expressed in monkey ganglia latently infected with SVV. J. Virol., 70, 5711-5715.
11. Cohen, J. I., Cox, E., Pesnicak, L., Srinivas, S., and Krogmann T. (2004). The varicellazoster virus ORF63 latency-associated protein is critical for establishment of latency. J. Virol., 78, 11833-11840.
12. Cohen, J. I., Krogmann, T., Bontems, S., Sadzot-Delvaux, C., and Pesnicak, L. (2005a). Regions of the varicella-zoster virus open reading from 63 latency-associated protein important for replication in vitro are also critical for efcient establish-ment of latency. J. Virol., 79, 5069-5077.
13. Cohen, J. I. and Straus, S. E. (2001). Varicella-zoster virus and its replication. In Fields Virology, ed. D. M. Knipe, P. M. Howley et al. pp. 2707-2730. Philadelphia, PA: Lippincott-Williams & Wilkins.
14. Cohen J. I., Krogmann, T., Ross, J. P. et al. (2005b). Varicella-zoster virus ORF4 latency-associated protein is important for estab-lishment of latency. J. Virol., 79, 6969-6975.
15. Cohrs R. J., Barbour, M. B., and Gilden, D. H. (1996). Varicella-zoster virus (VZV) transcription during latency in human ganglia: Detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol., 70, 2789-2796
16. Cohrs, R. J., Randall, J., Smith, J. et al. (2000). Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J. Virol., 74, 11464-11471.
17. Cohrs R. J., Gilden, D. H., Kinchington, P. R., Grinfeld, E., and Kennedy, P. G. E. (2003). Varicella-zoster virus gene 66 tran-scription and translation in latently infected human ganglia. J. Virol., 77, 6660-6665.
18. Croen, K. D., Ostrove, J. M., Dragovic, L. J., and Straus, S. E. (1988). Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl Acad. Sci. USA, 85, 9773-9777.
19. Debrus, S., Sadzot-Delvaux, C., Nikkels, A. F., Piette, J., and Rentier, B. (1995). Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol., 69, 3240-3245.
20. Dueland, A. N., Rannenbery-Nilsen, T., and Degre, M.(1995). Detec-tion of latent varicella-zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplication combined with in situ hybridization. Arch. Virol., 140, 2055-2066.
21. Efstathiou, S. E., Minson, A. C., Field, H. J., Anderson, J. R., and Wildy, P. (1986). Detection of herpes simplex virus-specic DNA sequences in latently infected mice and humans. J. Virol., 57, 446-455.
22. Furuta, Y., Takasu, T., Fukuda, S. et al. (1992). Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction. J. Infect. Dis., 166, 1157-1159.
23. Furuta, Y., Takasu, T., Suzuki, S., Fukuda, S., Inuyama, Y., and Nagashima, K. (1997). Detection of latent varicella-zoster virus infection in human vestibular and spiral ganglia. J. Med. Virol., 51, 214-216.
24. Gary, L., Gilden, D. H., and Cohrs, R. J. (2006). Epigenetic regula-tion of varicella-zoster virus open reading frame 62 and 63 in latently infected human trigeminal ganglia. J. Virol., 80, 4921-4926.
25. Gilden, D. H., Vafai, A., Shtram, Y., Becker, Y., Devlin, M., and Wellish, M.(1983). Varicella-zoster virus DNA in human sensory gan-glia. Nature, 306, 478-480.
26. Gilden, D. H., Rosenman, Y., Murray, R., Devlin, A., and Vafai, A. (1987). Detection of varicella-zoster virus nucleic acid in neu-rons of normal human thoracic ganglia. Ann. Neural., 22, 377-380.
27. Gilden, D. H., Gesser, R., Smith, J. et al. (2001). Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes, 23, 145-147.
28. Gray, W. L. (2004). Simian varicella: A model for human varicella-zoster virus infection. Rev. Med. Virol., 14, 363-381.
29. Gray, W. L., Starnes, B., White, M. W., and Mahalingam, R. (2001). The DNA sequence of the simian varicella virus genome. Virol-ogy, 284, 123-130.
30. Grinfeld, E. and Kennedy, P. G. E. (2004). Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes, 29, 317-319.
31. Grinfeld, E., Sadzot-Delvaux, C., and Kennedy, P. G. E. (2004). Varicella-zoster virus proteins encoded by open reading frames 14 and 67 are both dispensable for the establishment of latency in a rat model. Virology, 323, 85-90.
32. Hood, C. Cunningham, A. L., Slobedman, B., Boadle, R. A., and Abendroth, A. (2003). Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin broblasts are susceptible: Evidence for a cell-type-specic apoptotic response. J. Virol., 77, 12852-12864.
33. Hood, C., Cunningham, A. L., Slobedman, B., et al. (2006). Varicella-zoster virus ORF63 inhibits apoptosis of primary human neu-rons. J. Virol. 80, 1025-1031.
34. Hoover, S. E., Cohrs, R. J., Rangel, Z. G., Gilden, D. H., Munson, P., and Cohen, J. I. (2006). Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency. J. Virol. 80, 3459-3468
35. Hyman, R. W., Ecker, J. R., and Tenser, R. B. (1983). Varicella-zoster virus RNA in human trigeminal ganglia. Lancet, ii, 814-816.
36. Kennedy, P. G., Grinfeld, E., Bontems, S., and Sadzot-Delvaux, C.(2001). Varicella-zoster virus gene expression in latently infected rat dorsal root ganglia. Virology, 289, 218-223.
37. Kennedy, P. G., Grinfeld, E., Traina-Dorge, V., Gilden, D. H., and Mahalingam, R. (2004). Neuronal localization of simian vari-cella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes, 28, 273-276.
38. Kennedy, P. G. E., Grineld, E., and Gow, J. W. (1998). Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl Acad. Sci. USA, 95, 4658-4662.
39. Kennedy. P. G. E., Grinfeld, E., and Gow, J. W. (1999). Latent varicella-zoster virus in human dorsal root ganglia. Virology, 258, 451-454.
40. Kennedy, P. G. E., Grinfeld, E., and Bell, J. E. (2000). Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol., 74, 11893-11898.
41. Kinchington, P. R., Fite, K, and Turse, S. E. (2000). Nuclear accu-mulation of IE62, the varicella-zoster virus (VZV) major tran-scriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol., 74, 2265-2277.
42. Kress, M. and Fickenscher, H. (2001). Infection by human varicella-zoster virus confers norepinephrine sensitivity to sensory neurons from rat dorsal root ganglia. FASEB J., 15, 1037-1043.
43. Kristie, T. M., Vogel, J. L., and Sears, A. E. (1999). Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex from latency. Proc. Natl Acad. Sci., 96, 1229-1233.
44. LaGuardia, J. J., Cohrs, R. J., and Gilden, D. H. (1999). Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J. Virol., 73, 8571-8577.
45. Levin, M. J., Cai, G. Y., Manchak, M. D., and Pizer, L. I. (2003). Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J. Virol., 77, 6979-6987.
46. Lowry, P. W., Sabella, C., Koropchak, C. M. et al. (1993). Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction J. Infect. Dis., 167, 78-83.
47. Lungu, O., Annunziato, P. W., Gershon, A. et al. (1995). Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc. Natl Acad. Sci. USA, 92, 10980-10984.
48. Lungu, O., Panagiotidis, C. A., Annunziato, P. W., Gershon, A. A., and Silverstein, S. J. (1998). Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl Acad. Sci. USA, 95, 7080-7085.
49. Mahalingam, R., Wellish, M., Wolf, Q. et al. (1990). Latent varicella-zoster virus DNA in human trigeminal and thoracic ganglia. N. Engl. J. Med., 323, 627-631.
50. Mahalingam, R., Smith, D., Wellish, M. et al. (1991). Simian varicella virus DNA in dorsal root ganglia. Proc. Natl Acad. Sci. USA, 88, 2750-2752.
51. Mahalingam, R., Wellish, M., Lederer, D., Forghani, B., Cohrs, R., and Gilden, D. (1993). Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J. Virol., 67, 2381-2384.
52. Mahalingam, R., Wellish, M., Cohrs, R. et al. (1996). Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl Acad. Sci. USA, 93, 2122-2124.
53. Mahalingam, R., Traina-Dorge, V., Wellish, M., Smith, J., and Gilden, D.(2002). Naturally acquired simian varicella virus infection in African green monkeys. J. Virol., 76, 8548-8550.
54. Meier, J. L., Holman, R. P., Croen, K. D., Smialek, J. E., and Straus, S. E. (1993). Varicella-zoster virus transcription in human trigemi-nal ganglia. Virology, 193, 193-200.
55. Merville-Louis, M. P., Sadzot-Delvaux, S. Delree, P., Piette, J., Moo-nen, G., and Rentier, B. (1989). Varicella-zoster virus infection of adult rat sensory neurons in vitro. J. Virol., 63 3155-3160.
56. Moriuchi, H., Moriuchi, M., and Cohen, J. I. (1995). Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein. J. Virol., 69, 4693-4701.
57. Oxman, M. N., Levin, M. J., Johnson, G. R. et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia. N. Eng. J. Med., 352, 2271-2284.
58. Patel, Y., Gough, G., Cofn, R. S., Thomas, S., Cohen, J. I., and Latch-man, D. S. (1998). Cell type specic repression of the varicella-zoster virus immediate-early gene 62 promoter by the cellular Oct-2 transcription factor. Biochim. Biophys. Acta, 1397, 268-274.
59. Pevenstein, S. R., Williams, R. K., McChesney, D., Mont, E. K., Smialek, J. E., and Straus, S. E. (1999). Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J. Virol., 73, 10514-10518.
60. Sadzot-Delvaux, C., Merville-Louis, S., and Delree, M. P. (1990). An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J. Neurosci. Res., 26, 83-89.
61. Sadzot-Delvaux, C., Debrus, S., Nikkels, A., Piette, J., and Rentier, B. (1995). Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology, 45 (Suppl. 8), S18-S20.
62. Sadzot-Delvaux, C., Kinchington, P. R., Debrus, S., Rentier, B., and Arvin, A. M. (1997). Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J. Immunol., 159, 2802-2806.
63. Sato, H., Callanan, L. D., Pesnicak, L., Krogmann, T., and Cohen, J. I. (2002a). Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 C, but not 33 C. J. Virol., 76, 11012-11023.
64. Sato, H., Pesnicak, L., and Cohen, J. I. (2002b). Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J. Virol., 76, 3575-3578.
65. Sato, H., Pesnicak, L., and Cohen, J. I. (2003a). Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency. J. Med. Virol., 70 (Suppl 1), S79-S81.
66. Sato, H., Pesnicak, L., and Cohen, J. I. (2003b). Varicella-zoster virus ORF47 protein kinase which is required for replication in human T cells, and ORF66 protein kinase which is expressed during latency, are dispensable for establishment of latency. J. Virol., 77, 11180-11185.
67. Somekh, E., Tedder, D. G., Vafai, A. et al. (1992). Latency in vitro of varicella-zoster virus in cells derived from human fetal dorsal root ganglia. Pediatr. Res., 32, 699-703.
68. Stallings, C. L., Duigou, G. J., Gershon, A. A., Gershon, M. D., and Silverstein, S. J. (2006). The cellular localization pattern of varicella-zoster virus ORF29p is inuenced by proteosome-mediated degradation. J. Virol., 80, 1497-1512.
69. Theil, D., Paripovic, I., Derfuss, T. et al. (2003). Dually infected (HSV-1/VZV) single neruons in human trigeminal ganglia. Ann. Neu-rol., 54, 678-681.
70. Vafai, A., Murray, R. S., Wellish, M., Devlin, M., and Gilden, D. H. (1988). Expression of varicella-zoster virus and herpes simplexvirus in normal human trigeminal ganglia. Proc. Natl Acad. Sci. USA, 85, 2362-2366.
71. Wang, K., Lau, T. Y., Morales, M., Mont, E. K., and Straus, S. E. (2005). Laser-capture microdissection: Rening estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level. J. Virol. 79, 14079-14087.
72. White, T. M., Mahalingam, R., Traina-Dorge, V., and Gilden, D. H. (2002). Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J. Neurovirol., 8, 191-205.
73. Wigdahl, B., Rong, B. L., and Kinney-Thomas, E. (1986). Varicella-zostervirusinfectionofhumansensoryneurons. Virology, 152, 384-399.
74. Wroblewska, Z., Valyi-Nagy, T., Otte, J. et al. (1993). A mouse model forvaricella-zosterviruslatency. Microbiol. Pathogen., 15, 141-151.
75. Xia, D. M., Srinivas, S., Sato, H., Pesnicak, L., Straus, S. E., and Cohen, J. I. (2002). Varicella-zoster virus ORF21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency. J. Virol., 77, 1211-1218.
76. Zerboni, L., Ku, C.-C., Jones, C. D., Zehnder, J. L., and Arvin, A. M. (2005). Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl Acad. Sci. USA, 102, 6490-6495.
77. Zuranski, T., Nawar, H., Czechowski, D. et al. (2005). Cell-type-dependent activation of the cellular EF-1a. promoter by the varicella-zoster virus IE63 protein. Virology, 338, 35-42.